Boxer Capital, LLC Acadia Pharmaceuticals Inc Transaction History

Boxer Capital, LLC

  • $1.88 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$20.94 - $27.5 $22.6 Million - $29.7 Million
1,078,930 Added 583.21%
1,263,930 $30.6 Million
Q4 2021

Feb 14, 2022
BUY
$16.79 - $27.09 $3.11 Million - $5.01 Million
185,000 New
185,000 $4.32 Million
Q4 2020

Feb 16, 2021
SELL
$41.04 - $56.79 $15.2 Million - $21 Million
-370,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$31.65 - $46.87 $11.7 Million - $17.3 Million
370,000 New
370,000 $15.6 Million

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.63B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email